December 9, 2025 · Form 4 insider transaction
Cambrian BioPharma Inc bought 395 shares of SNSE at $6.40 per share, a transaction worth $2.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
These shares are held by Cambrian Biopharma, Inc., a Delaware corporation ("Cambrian"). The Chief Executive Officer of Cambrian, James Peyer, may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.